{"zip": "103-8668", "sector": "Healthcare", "fullTimeEmployees": 47495, "longBusinessSummary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a strategic alliance with Egle Therapeutics SAS and Evotec SE; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer; and strategic collaboration with Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.", "city": "Tokyo", "phone": "81 3 3278 2306", "country": "Japan", "companyOfficers": [], "website": "http://www.takeda.com", "maxAge": 1, "address1": "1-1, Nihonbashi-Honcho 2-chome", "fax": "81 3 3278 2268", "industry": "Drug Manufacturers\u2014Specialty & Generic", "address2": "Chuo-ku", "previousClose": 3722, "regularMarketOpen": 3680, "twoHundredDayAverage": 3753.163, "trailingAnnualDividendYield": 0.048361097, "payoutRatio": 1.5682001, "volume24Hr": null, "regularMarketDayHigh": 3703, "navPrice": null, "averageDailyVolume10Day": 6422950, "totalAssets": null, "regularMarketPreviousClose": 3722, "fiftyDayAverage": 3937.75, "trailingAnnualDividendRate": 180, "open": 3680, "averageVolume10days": 6422950, "expireDate": null, "yield": null, "algorithm": null, "dividendRate": 180, "exDividendDate": 1617062400, "beta": 1.167774, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 3653, "priceHint": 2, "currency": "JPY", "trailingPE": 32.573574, "regularMarketVolume": 6881200, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 5895698776064, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 6714777, "priceToSalesTrailing12Months": 1.8428435, "dayLow": 3653, "ask": 0, "ytdReturn": null, "askSize": 0, "volume": 6881200, "fiftyTwoWeekHigh": 4365, "forwardPE": 3169.4917, "fromCurrency": null, "fiveYearAvgDividendYield": 4.08, "fiftyTwoWeekLow": 3239, "bid": 0, "tradeable": false, "dividendYield": 0.0495, "bidSize": 0, "dayHigh": 3703, "exchange": "JPX", "shortName": "TAKEDA PHARMACEUTICAL CO LTD", "longName": "Takeda Pharmaceutical Company Limited", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "isEsgPopulated": true, "gmtOffSetMilliseconds": "32400000", "underlyingSymbol": null, "quoteType": "EQUITY", "symbol": "4502.T", "underlyingExchangeSymbol": null, "headSymbol": null, "messageBoardId": "finmb_874540", "uuid": "fb2ad09e-f947-34fe-9b90-a37a3155bad5", "market": "jp_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 3.213, "beta3Year": null, "profitMargins": 0.05646, "enterpriseToEbitda": 13.155, "52WeekChange": null, "morningStarRiskRating": null, "forwardEps": 1.18, "revenueQuarterlyGrowth": null, "sharesOutstanding": 1576390016, "fundInceptionDate": null, "annualReportExpenseRatio": null, "bookValue": 2965.003, "sharesShort": null, "sharesPercentSharesOut": null, "fundFamily": null, "lastFiscalYearEnd": 1585612800, "heldPercentInstitutions": 0.33931, "netIncomeToCommon": 180630994944, "trailingEps": 114.817, "lastDividendValue": null, "SandP52WeekChange": null, "priceToBook": 1.2613815, "heldPercentInsiders": 0.00104, "nextFiscalYearEnd": 1648684800, "mostRecentQuarter": 1609372800, "shortRatio": null, "sharesShortPreviousMonthDate": null, "floatShares": 1563073828, "enterpriseValue": 10278926286848, "threeYearAverageReturn": null, "lastSplitDate": null, "lastSplitFactor": null, "legalType": null, "morningStarOverallRating": null, "earningsQuarterlyGrowth": null, "dateShortInterest": null, "pegRatio": null, "lastCapGain": null, "shortPercentOfFloat": null, "sharesShortPriorMonth": null, "category": null, "fiveYearAverageReturn": null, "regularMarketPrice": 3680, "logo_url": "https://logo.clearbit.com/takeda.com"}